• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ECYT:US

6.2400 USD 0.00000.00%

As of 20:10:00 ET on 07/23/2014.

Snapshot for Endocyte Inc (ECYT)

Open: 6.2900 Day's Range: 6.1600 - 6.4400 Volume: 681,482
Previous Close: 6.2400 52wk Range: 6.0100 - 33.7000 1-Yr Rtn: -62.20%

Stock Chart for ECYT

No chart data available.
  • ECYT:US 6.2400
  • 1D
  • 1M
  • 1Y
6.2400
Interactive ECYT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ECYT

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.4800
Est. EPS (USD) (12/2014) -0.1120
Est. PEG Ratio -
Market Cap (M USD) 258.99
Shares Outstanding (M) 41.50
30 Day Average Volume 1,267,709
Price/Book (mrq) 2.5798
Price/Sale (ttm) 3.3314
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ECYT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ECYT

Endocyte Inc. is a biopharmaceutical company developing targeted therapies for the treatment of cancer and inflammatory diseases. The Company uses a proprietary technology to create small molecule drug conjugates, or SMDCs, and companion imaging diagnostics that actively target receptors that are over-expressed on diseased cells, relative to healthy cells.

P Ron EllisPresident/CEO/Co-FounderMichael A ShermanCFO/COO
Philip S LowChief Science OfficerDavid D MeekChief Commercial Officer
More Company Profile & Key Executives for ECYT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil